Today: 30 April 2026
Salesforce (CRM) stock price today: shares rise ahead of earnings as traders brace for a big move
25 February 2026
1 min read

Salesforce (CRM) stock price today: shares rise ahead of earnings as traders brace for a big move

NEW YORK, Feb 25, 2026, 11:35 ET — Regular session

  • Salesforce shares climbed roughly 2% in late-morning trading, with investors waiting for results due after the bell.
  • Options are pricing in about a 9% move, up or down, following earnings by Friday.
  • Watch AI demand trends—Agentforce stands out—and keep an eye on guidance for next year.

Shares of Salesforce, Inc. picked up close to 2%, reaching $189.26 on Wednesday while traders set up ahead of the company’s quarterly results after the bell. The stock swung from $182.26 to $191.26 during the session, still hovering near the bottom of its 52-week range.

With traders bracing for a bumpy ride, options prices signal Salesforce shares could move as much as 9% either way by week’s end, Investopedia noted. That range would set the stock somewhere between $162 and $194 based on Monday’s close. Analysts polled by Visible Alpha are calling for adjusted EPS of $3.05, alongside a 12% jump in revenue to $11.18 billion.

After a turbulent February, broader markets found firmer ground, tech names regaining traction as Nvidia’s earnings take center stage on Wednesday. “I see AI disruption continuing as a dominant market theme through this year,” said Sam Stovall, CFRA’s chief investment strategist, noting the shifting flows between software and other sectors. Reuters

Salesforce ended Tuesday at $185.42, up roughly 4% for the session, Investing.com data shows.

Dan Ives at Wedbush is looking for “solid results,” even as talk of an “AI Ghost Trade” keeps pressure on the stock, according to a note picked up by Finviz. KeyBanc’s Jackson Ader flagged a shift in “channel conversations” around Agentforce—pilots are converting to contracts now. Over at Freedom Capital Markets, strategist Jay Woods thinks the company could “rebuke the AI disruption narrative.” Finviz

Enterprise software remains under pressure. Shares of Workday tumbled after the company’s latest sales forecast disappointed, reviving concerns over the resilience of legacy software demand as AI tools gain ground. The S&P 500 Application Software index has dropped roughly 29% year-to-date, according to Reuters.

The quarter isn’t the only hurdle. Traders are moving stocks on guidance—and on any whiff that clients might be reining in spending or holding off on major purchases, particularly when it comes to fresh AI add-ons.

Salesforce plans to announce its fourth-quarter and full-year fiscal 2026 results after the bell, with a conference call set for 5:00 p.m. ET. The focus will be on the speed at which AI offerings are converting to paying deals, as well as management’s take on demand heading into the new fiscal year.

Stock Market Today

  • Cartier Heir Sentenced to 8 Years for $470M Drug Money Crypto Laundering Scheme
    April 30, 2026, 3:26 PM EDT. Maximilien de Hoop Cartier, descended from the Cartier jewelry family, was sentenced to eight years in federal prison for running an unlicensed cryptocurrency exchange that laundered over $470 million in drug money. The scheme involved shell companies posing as software firms and broke transactions into smaller amounts to evade bank detection. Cartier pleaded guilty to money transmission without a license and bank fraud conspiracy in Manhattan federal court. Authorities seized nearly $940,000 in 2021, and Cartier was ordered to forfeit over $2.3 million and multiple bank accounts. U.S. Attorney Jay Clayton condemned Cartier's exploitation of financial systems for laundering drug proceeds. Cartier also maintains a social media presence as a singer under the name 'Max Cartier.'

Latest article

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

Rezolve AI Stock Rises After Revenue Tops All of 2025 in 90 Days

30 April 2026
Rezolve AI reported $60 million in first-quarter revenue, surpassing its audited 2025 total of $46.8 million, based on unaudited accounts. Shares rose 4.9% after the update. The company reaffirmed its $360 million 2026 revenue target and said it can reach profitability without new equity sales. Commerce.com, which rejected Rezolve’s all-stock takeover offer, adopted a poison pill defense.
Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

Option Care Health Stock Plunges After 2026 Revenue Cut Exposes Chronic-Therapy Drag

30 April 2026
Option Care Health shares fell 28% to $19.44 after the company cut its 2026 revenue forecast and reported first-quarter sales of $1.35 billion, missing estimates. The company now expects 2026 revenue of $5.675–$5.775 billion, down from a prior range of $5.8–$6.0 billion, citing pressure in its chronic inflammatory disease portfolio. Adjusted profit guidance was unchanged.
Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

Stellantis N.V. Stock Slides: Q1 Profit Rebound Leaves One Big Cash-Flow Question

30 April 2026
Stellantis reported a first-quarter net profit of €377 million, reversing a €387 million loss a year earlier, aided by a €400 million expected U.S. tariff refund. Industrial free cash flow remained negative at €1.92 billion. Shares fell 6.4% to €6.22 after the results. CEO Antonio Filosa faces pressure ahead of a May 21 investor day to present a stronger turnaround plan.
Meta stock rises after $60 billion AMD AI chip pact, with Nvidia earnings next
Previous Story

Meta stock rises after $60 billion AMD AI chip pact, with Nvidia earnings next

Visa stock rebounds after AI scare rattles payments, with Nvidia earnings the next test
Next Story

Visa stock rebounds after AI scare rattles payments, with Nvidia earnings the next test

Go toTop